Jamie Hartmann-Boyce Research Associate, Cochrane Tobacco Addiction Review Group, Department of Primary Care Health Sciences, University of Oxford
Monaz Mehta Managing Editor, Cochrane Tobacco Addiction Review Group, Department of Primary Care Health Sciences, University of Oxford
Abstract
Practitioners and researchers need to be aware of all the evidence informing a clinical problem or research project. Relying on the most recent, largest, or highest profile trial may give a misleading view of treatment effects. High quality meta-analyses benefit clinical practice and research, and finding and interpreting systematic reviews and meta-analyses is a necessary skill.
This workshop will (1) educate practitioners and scientists about using and interpreting findings from Cochrane reviews, (2) explain the rationale underlying the standard methods used by Cochrane Tobacco Addiction Group for meta-analyses of cessation interventions, and (3) discuss ongoing and future initiatives within the Cochrane Collaboration and Cochrane Tobacco Addiction Review Group.
Interactive exercises will focus on building skills for reading and using systematic reviews in practice, including interpretation of forest plots and Summary of Findings tables, and participants will be encouraged to ask questions throughout. The session will conclude with a group discussion about use of Cochrane reviews in clinical environments, and how reviews could be further improved to meet the needs of tobacco cessation practitioners.
Source of funding: The Cochrane Tobacco Addiction Group is part of the international Cochrane Collaboration, an independent not-for-profit consortium dedicated to providing up-to-date, accurate information about the effects of health care. The National Institute for Health Research (NIHR) is the largest single funder of this Cochrane Review Group.
